CHELSEA SMITH: Open Payments
NPI 1346716693 · DEKALB, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 21 payments from 8 companies in 2025. Trend: 2023 $84 · 2024 $13 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Amgen Inc. | 5 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: LEQVIO, REPATHA, VERQUVO, CAMZYOS, CAPVAXIVE, Kerendia, ONPATTRO, ELIQUIS.
Industry payments across IL — which companies pay providers there.
